Rafferty Asset Management, LLC Akero Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 90,401 shares of AKRO stock, worth $2.58 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

90,401

Previous 121,014 25.3%

Holding current value

$2.58 Million

Previous $2.84 Million 8.63%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$21.45 - $29.34 $656,648 - $898,185	-30,613 Reduced 25.3%	90,401 $2.59 Million
Q2 2024 Aug 13, 2024	SELL	$18.31 - $24.62 $3.17 Million - $4.26 Million	-173,099 Reduced 58.85%	121,014 $2.84 Million
Q1 2024 May 13, 2024	SELL	$17.76 - $31.18 $2.8 Million - $4.92 Million	-157,719 Reduced 34.91%	294,113 $7.43 Million
Q4 2023 Feb 13, 2024	BUY	$11.38 - $50.33 $3.05 Million - $13.5 Million	268,335 Added 146.23%	451,832 $10.6 Million
Q3 2023 Nov 13, 2023	BUY	$41.19 - $52.25 $1.04 Million - $1.32 Million	25,225 Added 15.94%	183,497 $9.28 Million
Q2 2023 Aug 11, 2023	SELL	$36.89 - $56.88 $229,861 - $354,419	-6,231 Reduced 3.79%	158,272 $7.39 Million
Q1 2023 May 11, 2023	SELL	$37.27 - $50.24 $868,241 - $1.17 Million	-23,296 Reduced 12.4%	164,503 $6.29 Million
Q4 2022 Feb 13, 2023	BUY	$33.44 - $54.8 $6.28 Million - $10.3 Million	187,799 New	187,799 $10.3 Million
Q2 2022 Aug 12, 2022	SELL	$8.0 - $15.01 $539,640 - $1.01 Million	-67,455 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$12.97 - $22.26 $146,509 - $251,448	11,296 Added 20.11%	67,455 $957,000
Q4 2021 Feb 10, 2022	BUY	$19.87 - $26.24 $280,862 - $370,902	14,135 Added 33.64%	56,159 $1.19 Million
Q3 2021 Nov 10, 2021	SELL	$18.65 - $25.46 $93,697 - $127,911	-5,024 Reduced 10.68%	42,024 $939,000
Q2 2021 Aug 10, 2021	SELL	$24.81 - $32.35 $5,507 - $7,181	-222 Reduced 0.47%	47,048 $1.17 Million
Q1 2021 May 10, 2021	BUY	$24.04 - $34.19 $924,289 - $1.31 Million	38,448 Added 435.82%	47,270 $1.37 Million
Q4 2020 Feb 10, 2021	BUY	$25.12 - $29.89 $221,608 - $263,689	8,822 New	8,822 $228,000

Others Institutions Holding AKRO

# of Institutions

190

Shares Held

73.8M

Call Options Held

241K

Put Options Held

647K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.33B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Akero Therapeutics, Inc. Transaction History